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ABSTRACT A central theme in prion protein research is the detection of the process that underlies the conformational transition
from the normal cellular prion form (PrPC) to its pathogenic isoform (PrPSc). Although the three-dimensional structures of
monomeric and dimeric human prion protein (HuPrP) have been revealed by NMR spectroscopy and x-ray crystallography, the
process underlying the conformational change from PrPC to PrPSc and the dynamics and functions of PrPC remain unknown. The
dimeric form is thought to play an important role in the conformational transition. In this study, we performed molecular dynamics
(MD) simulations on monomeric and dimeric HuPrP at 300 K and 500 K for 10 ns to investigate the differences in the properties of
the monomer and the dimer from the perspective of dynamic and structural behaviors. Simulations were also undertaken with
Asp178Asn and acidic pH, which is known as a disease-associated factor. Our results indicate that the dynamics of the dimer and
monomer were similar (e.g., denaturation of helices and elongation of the b-sheet). However, additional secondary structure
elements formed in the dimer might result in showing the differences in dynamics and properties between the monomer and
dimer (e.g., the greater retention of dimeric than monomeric tertiary structure).
INTRODUCTION
Transmissible spongiform encephalopathies are neurodegen-
erative diseases that are attributable to the structural trans-
formation of cellular prion (PrPC) to its anomalous isoform
(PrPSc). In humans, these diseases include kuru, Creutzfeldt-
Jakob disease, fatal familial insomnia, and Gerstmann-
Stra¨ussler-Scheinker syndrome; in sheep, scrapie; and in
cattle, bovine spongiform encephalopathy. The most impor-
tant aspect of prion disease is the conformational transition of
PrPC to PrPSc, both of which are isoforms with identical
amino acid sequence. However, comparison of the secondary
structures shows that PrPC is ;42% helical with a very
low (;3%) b-sheet content, whereas PrPSc consists of 30%
a-helices and 43% b-sheets. Although the precise physio-
logical role of PrPC and the chemical differences between
PrPC and PrP remain unknown, it appears that the differences
are conformational (Pan et al., 1993; Safar et al., 1993).
The three-dimensional structures of monomeric PrPCs
from various sources have been determined by NMR
spectroscopy (Riek et al., 1996; Donne et al., 1997; Zhang
et al., 1997; Lopez et al., 2000; Zahn et al., 2000) and found
to be very similar among many species. The N-terminal
region (residues 23–124) is ﬂexible, and the C-terminal
region (residues 125–228) that contains the globular
domains is well structured. All of these structures contain
intramolecular disulﬁde bridges, three a-helices, and a short
double-stranded b-sheet (Fig. 1 a). Recent x-ray crystallo-
graphic studies determined the dimeric form of human PrPC
(Knaus et al., 2001). The dimer is the result of three-
dimensional swapping of the C-terminal helix 3 and re-
arrangement of the disulﬁde bonds (Fig. 1 b). The transition
process from PrPC to PrPSc has been explained by two pop-
ular models. According to the heterodimer model (Prusiner,
1991; Cohen et al., 1994), PrPSc induces the conformational
change of PrPC by contact. The nucleation-dependent
polymerization model of Lansbury and Caughey (1995),
on the other hand, suggests that PrPSc acts as a crystal seed at
the starting point for crystal-like growth of a PrPSc oligomer
and that conformational change occurs via transient in-
teraction between PrPC and PrPSc. Several mutations in the
primary structure of PrPC are known to segregate in a variety
of transmissible spongiform encephalopathies (Prusiner,
1996). In this study, we selected the Asp178Asn (D178N)
mutation known to be associated with fatal familial insomnia
(Met129/Asn178). In the D178N mutation, the change from
a positively charged to an uncharged residue may affect the
hydrogen-bonding network and salt bridge (Riek et al.,
1998). Recombinant forms of human and murine PrPC
manifest a pH-dependent conformational change in the pH
range of 4.4–6, a loss of helix, and a gain of strands
(Swietnicki et al., 1997; Hornemann andGlockshuber, 1998).
Lower pH values accelerated conversion in a cell-free
conversion assay (Kocisko et al., 1995). Thus, acidic pH may
play a role in facilitating the conformational change that
ultimately results in the formation of PrPSc.
More recent conformational conversion models focus on
intra- and intermolecular disulﬁde bonds (Welker et al.,
2001, 2002; Tompa et al., 2002). Some experiments have
suggested that intramolecular disulﬁde bonds in PrPC are
required for its conversion to PrPSc (Muramoto et al., 1996;
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Herrmann and Caughey, 1998; Maiti and Surewicz, 2001).
To weaken these disulﬁde bonds, a hypothetical molecular
chaperone may be necessary (Telling et al., 1995; Kaneko
et al., 1997).
Dimerization is usually required for proteins to evolve
oligomeric proteins (Monod et al., 1965).With respect to PrP,
Meyer et al. (2000) reported a monomer-dimer equilibrium
under native conditions in a fraction of PrPC from bovine
brain (Meyer et al., 2000). Others have suggested that three-
dimensional domain-swapping-dependent oligomerization
is an important step in the conformational change of PrPC to
PrPSc (Knaus et al., 2001; Riley et al., 2002; Tompa et al.,
2002). However, the function and dynamics of the dimeric
form of PrPC remain to be elucidated.
Molecular dynamics (MD) simulations are widely used
to simulate the motion of molecules to gain a deeper un-
derstanding of the chemical reactions, ﬂuid ﬂow, phase
transitions, and other physical phenomena due to molecular
interactions (Hansson et al., 2002). Rapidly increasing
computational power has made MD simulation a powerful
tool for studying the structure and dynamics of biologically
important molecules. Taking into account all electrostatic
interactions by using the particle-mesh Ewald (PME)
method, relatively long (2–3 ns) simulations with the explicit
solvent water box can be carried out (Darden et al., 1993,
1999). Day et al. (2002) have shown that by increasing the
temperature, protein unfolding can be accelerated without
changing the pathway of unfolding, and that this method is
suitable for elucidating the details of protein unfolding at
minimal computational expense. With these methods, one
can obtain proper trajectories that reﬂect the conformational
and dynamic characteristics of molecules at each time point
during simulation.
Most reported MD simulations of PrPC have been reported
(Zuegg and Greedy, 1999; Guilbert et al., 2000; Wong et al.,
2000; Parchment and Essex, 2000; El-Bastawissy et al.,
2001; Gsponer et al., 2001; Okimoto et al., 2002), involved
short simulation times of\2 ns or were performed using the
AMBER ff94 force ﬁeld (Cornell et al., 1995), and all of the
previously reported simulation targets were the monomer.
Higo et al. (2001) used the multi-canonical method to show
that the ff96 force ﬁeld (Kollman et al., 1997) reproduces the
energy landscape more correctly than does the ff94 force
ﬁeld both in vacuo and in solvent water. We now report the
ﬁrst MD simulation of the dimeric PrPC conformation. The
aim of our study was to assess differences in the functions
and dynamics of the PrP monomer and dimer. We performed
eight 10-ns MD simulations of PrPC dimer and monomer
using the AMBER ff96 potential under different experimen-
tal conditions: a temperature of 300 K and 500 K, D178N
mutant, and acidic pH.
MATERIALS AND METHODS
All simulations were performed with the AMBER 7 program package (Case
et al., 2002) using the ff96 force ﬁeld. The starting structures were human
cellular prion protein (HuPrPC) entry 1QM2 (residues 125–228; Zahn et al.,
2000) as a monomer model and 1I4M (chain A, residues 119–226; chain B:
residues 227–334; Knaus et al., 2001) as a dimer model in the Brookhaven
Protein Data Bank (Berman et al., 2000; Westbrook et al., 2002). We built
the dimeric form of PrPC from 1I4M using Insight II. There are disulﬁde
bonds between Cys179–Cys214 in the monomer and between Cys179–Cys311
and Cys214–Cys287 in the dimer. To establish an acidic pH environment,
Asp, Glu, and His residues were protonated. The systems were surrounded
with a 20-A˚ layer of TIP3P water molecules (Jorgensen et al., 1983) and
neutralized by sodium ions using the LeaP module of AMBER 7. The
number of solvent water molecules and counterions in each system are
shown in Table 1. The solvated proteins with their counterions were
minimized by 1000 conjugate gradient steps, heated from 0 to 300 K during
35 ps at temperature increments of 50 K every 5 ps, and kept at 300 K within
20 ps using the constant pressure and temperature algorithm (Berendsen
et al., 1984). The SHAKE algorithm (Ryckaert et al., 1977) and PME
algorithm with nonbonded cutoffs of 8 A˚ were used during heating. After
equilibration, the production MD phase was carried out at 300 or 500 K for
10 ns using the constant volume and temperature ensemble and the PME
algorithm with nonbonded cutoffs of 8 A˚ during simulation. All simulations
were performed on the Magi (massively parallel computer for genome
informatics) cluster running SCore 4.1 (Hori et al., 1996) at the
Computational Biology Research Center. During the data-collection stage,
the structures were saved to ﬁle every 250 fs. Secondary structures were
analyzed using DSSP software (Kabsch and Sander, 1983), and images of
simulated proteins were generated using MOLMOL software (Koradi et al.,
1996).
RESULTS AND DISCUSSION
Simulation stability
Fig. 2 shows the Ca root-mean-square deviations (RMSDs)
from the initial structures of globular domains of HuPrPs. In
this paper, we deﬁne residues 129–223 [including strand
FIGURE 1 Schematic ribbon diagram of HuPrPc: (a) monomer; (b)
dimer.
TABLE 1 Simulation conditions
No. of ions No. of water molecules
WT
Monomer 3 Na1 6814
Dimer 8 Na1 9374
D178N
Monomer 2 Na1 6807
Dimer 6 Na1 9373
Acidic pH
Monomer 15 Cl 7168
Dimer 28 Cl 9714
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1 (S1), helix 1 (H1), strand 2 (S2), helix 2 (H2), and helix
3 (H3)] of the monomer and dimer (chain A) as globular
domains. As we encountered few differences in the Ca
RMSD values for each dimeric subunit (data not shown),
averaged data were used to present our results. In Fig. 2, a–c,
simulation data at 300 K are shown as control data. In
the simulation at 300 K, the Ca RMSD values for both
the monomer and the dimer remained relatively low for
a duration of 10 ns, although the monomer deviated from the
initial structure more than the dimer. The average RMSD
values of the monomer and dimer in the last 5 ns were 2.18
and 1.27 A˚, respectively. In Fig. 2 a, at 500 K, the Ca RMSD
values of the monomer increased and reached 9.01 A˚ at 6.6
ns. In contrast, the Ca RMSD values of the dimer increased
gently; the peak deviation was 4.7 A˚ at 9.2 ns. The average
RMSD values of the monomer and dimer in the last 5 ns
were 6.63 A˚ and 3.23 A˚, respectively, indicating that the
monomer increased faster than the dimer. This tendency was
a characteristic common to simulations at 300 K and 500 K.
In Fig. 2, b and c, under conditions of D178N and acidic pH,
the Ca RMSD values of both the monomer and the dimer
showed the same tendency as they did at 300 K. At D178N,
the peak values of Ca RMSD values were 2.76 A˚ and 1.32
A˚, respectively. The average Ca RMSD values of the
monomer and dimer in the last 5 ns were 1.72 A˚ and 1.44 A˚,
respectively, indicating that little conformation change oc-
curred in the protein tertiary structure. At acidic pH values,
the monomer and dimer peak Ca RMSD values were 2.86 A˚
at 4.45 ns and 2.81 A˚ at 9.94 ns, respectively. The average
RMSD values of the monomer and dimer in the last 5 ns
were 2.01 A˚ and 2.05 A˚.
Secondary structure evolution
Figs. 3 and 4 show the secondary structure evolution during
simulation as determined by the DSSP program (Kabsch
and Sander, 1983). Figs. 5 and 6 are ribbon illustrations of
snapshots of the trajectories. Figs. 3 a and 5 a depict
simulation results of monomer HuPrP at 300 K. Although
residues 152–156 of the H1 region formed a 310-helix or
H-bonds over a 0.0–7.0-ns period, after 8.0 ns they formed
an a-helix. Other secondary structure elements (S1, S2, H2,
and H3) were retained throughout the simulation; however,
several elongated S1 and S2 elements were observed until
4.0 ns (see the snapshot at 3.0 ns in Fig. 5 c). As shown in
Figs. 3 b and 5 b, at;2.0 ns at 500 K, the monomer began to
unfold in the b-sheet and at the C-terminus of H2 and H3. It
appears that the degradation of the helices corresponds with
the increase in Ca RMSD observed from 2.0 to 4.0 ns (Fig.
2 a). We noted subsequent changes in the secondary structure
at 4.0–6.0 ns: 1), the transient formation of nonnative
b-sheets at residues 129–130 and 222–223 and residues 132–
133 and 159–160 and their unfolding, 2), the unfolding of
the C-terminus of H2, and 3), the unfolding and refolding of
H1 (Fig. 5 d). These changes produced a rapid increase in the
Ca RMSD of the monomer to 7.2 A˚ at 4.6 ns (Fig. 2 a).
Although the simulation at 500 K was denaturation sim-
ulation, we can consider the results as conformational search
at 500 K. Fig. 5 d shows the denaturation state of H1 at
4.55 ns, the elongated S1 and S2 elements, and the ad-
ditional b-sheet at 4.65 ns. Glockshuber et al. (1997) and
Korth et al. (1997) demonstrated that the structure of H1 is
different between PrPC and PrPSc and suggested this region
might form b-sheet. There were notable changes in sec-
ondary structure elements from 6.0 to 7.0 ns. Therewere some
instances of ﬂuctuation in the loop and the Ca RMSD value
reached 9.01 A˚ at 6.6 ns. At 300 and 500 K, compari-
son with the monomer revealed that the dimer contained
two additional structural elements, helices H9 (residues 194–
197 and 302–305) and a b-sheet S9 (residues 191–193 and
299–301), that formed subunit interfaces (Fig. 3, c and d). At
300 K, all elements including S9 and H9 were retained
throughout the simulation, although there was slight dis-
ruption at some points (see Fig. 3 c). The C-terminus of H1
tended to form a 310-helix. In H2, H3, and H9, there were
several H-bonds. At 500 K, the C-terminus of helices
crumbled like that of monomer (Fig. 3 d). Our results imply
that in both the monomer and the dimer, there is a tendency
for H1, H2, and H3 to unfold, and that they share con-
formational vulnerability in these regions. Although in both
the monomer and dimer we noted a similar tendency for the
denaturation of several regions, the dimeric form retained
a remnant of the initial structure (Fig. 5 e). S1, S2, and S9
were retained throughout the simulation. In fact, as shown in
Fig. 2 a, the Ca RMSD values of the dimer increased more
slowly than those of the monomer. Intersubunit interactions
FIGURE 2 RMSD values of Ca from the
initial structures. (a–c) Red and blue lines
indicate RMSD values of the dimer and the
monomer at 300 K, respectively. (a) Green and
pink lines indicate RMSD values of the dimer
and the monomer at 500 K, respectively. (b)
Green and pink lines indicate RMSD values of
the dimer and the monomer at D178N, re-
spectively. (c) Green and pink lines indicate
RMSD values of the dimer and the monomer at
acidic pH, respectively.
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of H9, S9, and H1 and its molecular size (weight) may con-
tribute to solidity of the dimer.
At D178N, residues 167–169 and 275–277 (residues 167–
169 in chain B) in the dimer were mainly H-bonds; however,
the helices were similar to those seen at 300 K (Fig. 4, a and
c). In both the monomer and dimer, we noted several
elongations of b-sheets, which were more pronounced in the
monomer (Fig. 4, a and c, and Fig. 6, a and c).
FIGURE 3 Secondary structure as a function of simulation time determined with DSSP. (a) Monomer at 300 K; (b) monomer at 500 K; (c) dimer at 300 K;
and (d ) dimer at 500 K. The a-helix is shown in green, the 310-helix in light green boxes, the b-strand in red boxes, the b-bridge in blue boxes, the bend in pink
boxes, and the H-bond in yellow boxes.
FIGURE 4 Secondary structure as a function of simulation time determined with DSSP. (a) Monomer at acidic pH and (b) dimer at acidic pH. The a-helix is
shown in green, the 310-helix in light green boxes, the b-strand in red boxes, the b-bridge in blue boxes, the bend in pink boxes, and the H-bond in yellow
boxes.
MD Simulation of Dimeric Prion Protein 1179
Biophysical Journal 85(2) 1176–1185
At acidic pH values, several H-bonds were formed at the
C-terminus of H1 in the dimer; however, the helices were
similar to those seen at 300 K (Fig. 4, b and d). In both
the monomer and dimer, we noted several elongations of
b-sheets, which were more pronounced in the monomer (Fig.
4, b and d, and Fig. 6, b and d ).
Percentage of secondary structure
Fig. 7 shows the percentage (abundance ratio) of secondary
structures per residue throughout the simulation. At 300 K,
the a-helix, H1, and H2 were longer in the monomer than
the dimer. In H1, there seemed to be a predilection for
elongating to the C-terminus side (Fig. 7 a) and a simulta-
neous tendency of the C-terminus to form a 310-helix in the
monomer. S1 tended to elongate to the C-terminus side
whereas S2 exhibited a tendency for elongation to the
N-terminus side (Fig. 5 c) in both the monomer and dimer.
S9 remained intact throughout the simulation.
At 500 K, fewer a-helices, 310-helices, and b-sheets were
formed than at 300 K (Fig. 7 b). Monomeric H1, H2, and H3
tended to denature more than their dimeric counterparts.
FIGURE 5 (a) Temporal history of
the monomer at 300 K; (b) temporal
history of the monomer at 500 K; (c)
one snapshot of the monomer at 300 K;
(d ) details of temporal history of the
monomer at 500 K around 4.6 ns; (e)
temporal history of the dimer at 300 K;
and ( f ) temporal history of the dimer at
500 K.
FIGURE 6 Temporal history of (a)
the monomer at D178N; (b) the mono-
mer at acidic pH; (c) the dimer at
D178N; and (d ) the dimer at acidic pH.
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H2 tend to elongate to the C-terminus side whereas H3
exhibited a tendency for elongation to the N-terminus side in
the monomer. Fewer S1 and S2 elements were noted in the
monomer than the dimer. S1 tended to elongate to the
C-terminus side whereas S2 exhibited a tendency for
elongation to the N-terminus side in both the monomer and
dimer (Fig. 5 d).
Many of the secondary structures in both the monomer
and dimer were similar at D178N to those observed at 300 K,
conﬁrming the Ca RMSD values from the initial structure
ﬁndings (Fig. 2 b). In comparison with 300 K, at D178N
residues 167–169 (both ends of the dimeric PrPc) revealed an
H-bond instead of a 310-helix in the dimer. In the dimer, S1
and S2, but especially monomeric elements, tend to elongate
to the C-terminus side and the N-terminus side, respectively.
At acidic pH values, some secondary structures were
different from those seen at 300 K (Fig. 7 d) and the
elongation of H1 in the monomer to the C-terminus side was
more pronounced. Dimeric residues 167–169 mainly formed
310-helices. S1 and S2 in the dimer of chain A decreased
probability to form b-sheets and it made b-bridges instead
(Figs. 5 b and 6 b). In both the monomer and dimer, S1 and
S2, but especially monomeric elements, tend to elongate to
the C-terminus side and the N-terminus side, respectively
(Figs. 5 and 6).
Fig. 7 shows that in both the monomer and the dimer but
especially in the monomeric elements, S1 and S2 tended to
elongate to the C-terminus side and the N-terminus side,
respectively, at 300 K and acidic pH.
Positional RMSD from the average structure
Because we were unable to detect major differences in the
results obtained at 300 K, D178N, and acidic pH, we present
our results obtained with simulations at 300 K and 500 K.
Fig. 8 shows Ca RMSD values from the mean structure as
a function of residue number and is suitable for describing
the ﬂexibility differences among the residues. Because there
were few differences between the RMSD proﬁles of chains A
and B in the dimer (data not shown), only chain A is
depicted. In order, the Ca RMSD values increased for the
dimer at 300 K, the monomer at 300 K, the dimer at 500 K,
and the monomer at 500 K. Fluctuations at positions 1
(Arg136), 2 (Phe141), 3 (Tyr157), and 4 (Asp168) were far
larger than were ﬂuctuations of other residues. The residues
exhibiting the large ﬂuctuations correspond with the loop
regions, and at 300 K, only loop regions manifested
ﬂuctuations. Interestingly, a region adjacent to position 4
(residues 169–171) is a putative binding site for protein X
(Kaneko et al., 1997), and NMR showed it to be ﬂex-
FIGURE 7 Percentage of secondary structure per residue during simulations at (a) 300 K, (b) 500 K, (c) D178N, and (d ) acidic pH. Red and green indicate
the monomer and dimer, respectively. Lines above each ﬁgure show the initial structure.
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ible(Viles et al., 2001). Resonances of the loop are not
observed in HuPrP due to conformational exchange. At
position 6 (Gly195), the Ca RMSD values in the monomer
increased to 19.9 A˚ at 500 K. At the same temperature, the
same residue of the dimer increased to only 5.96 A˚. This
is consistent with Fig. 3 d, which shows that S9 and H9
stabilized this region. The smallest ﬂuctuations were
observed at positions 5 (Cys179) and 7 (Cys214) in H2 and
H3, where residues Cys179–Cys214 of the monomer, and
Cys179–Cys322 and Cys214–Cys287 of the dimer are con-
nected by disulﬁde bridges and contribute to the stabilization
of neighboring regions. It appears that H2 and H3 form
a relatively stable core of the protein and MD simulations of
the prion from Syrian hamster indicated that the remainder of
the protein has a degree of conformational plasticity (Parch-
ment and Essex, 2000). Studies that mapped antibodies to
various epitopes on PrP (Peretz et al., 1997) also support the
hypothesis that a core of the molecule containing H2 and H3
remains intact after the conversion of PrPC to PrPSc.
Ca contact maps
Analyses of the close contacts throughout the simulations are
shown in Fig. 9. The degree of each native contact during the
simulations is depicted in red, pink, green, yellow, and blue
in decreasing order. In Fig. 9, a and b, region 1 is the area
of contact between S1 and H1 to just after S2, region 2
facilitates contact between S2 and H2, region 3 between H2
and H3, region 4 from the loop just after H1 to the loop
connecting S2 with H2, and in region 5, contact occurs
between the area just before S1 to H1 and H3. Monomers
and dimers share many similarities in these regions. Regions
6 and 7, however, are unique to the dimer and comprise the
dimer interface. Region 6 is the contact between H1 of chain
A and H1 of chain B, and region 7 provides for contact
between H9 and S9 of chain A and their counterparts in chain
B. Fig. 9 d shows that during simulation at 500 K, most of
the native interactions in the dimer lasted longer than those in
the monomer (Fig. 9 b).
FIGURE 8 Ca RMSD values from the average structure as a function of
residue number. Red, blue, green, and pink lines indicate RMSD values of
the dimer at 300 K, monomer at 300 K, dimer at 500 K, and monomer at 500
K, respectively.
FIGURE 9 Ca contact maps. (a) Monomer
at 300 K; (b) monomer at 500 K; (c) dimer at
300 K; and (d ) dimer at 500 K. The distance of
Ca was 11 A. The existence ratio of contact
0–20% is shown in blue, 20–40% in yellow,
40–60% in green, 60–80% in pink, and 80–
100% in red.
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SUMMARY
PrP exists in not only a monomeric but also a dimeric form
(Meyer et al., 2000; Knaus et al., 2001). Recent models
suggest that dimerization plays an important role in the
conformational change of PrPC to PrPSc (Tompa et al.,
2002). Although earlier MD simulations have yielded
information on the monomeric form of PrPC, data on its
dimeric form remain scarce. To elucidate the conformational
change of PrPC to PrPSc, the dynamics of the dimeric form of
PrPC must be known. Therefore, we performed totally
monomeric 40-ns simulations and dimeric 40-ns simulation
in various conditions. Our conclusion that the monomer
started denaturing earlier than the dimer is based on results
we obtained in our study of Ca RMSD values from the initial
structures (see Fig. 2), of secondary structure evolution
during simulation (see Fig. 3), and of structures representa-
tive of conformational changes (see Fig. 5). Our results also
showed that a-helices in both the monomer and dimer
denatured in a similar manner (see Fig. 3). As the rate of
protein denaturation is molecular weight-dependent, the
greater retention of dimeric than monomeric tertiary and
secondary structures is expected. However, we observed that
in the dimer, the helices were denatured more readily
whereas the tertiary structure was retained more than in the
monomer. This suggests that the dimer interface, H’ helices
(residues 194–197 and 302–305), and an S9 b-sheet
(residues 191–193 and 299–301) play an important role in
the inhibition of tertiary structure of denaturalization. Al-
though the discussion above was based on the simulation
at 500 K, which was performed only one time for each prion
model, the results potentially have biological importance. In
our simulations, S1 and S2 in the dimer and especially the
monomer tended to elongate to the C- and N-terminal sides,
respectively, under most of the experimental conditions (see
Figs. 4–7). This suggests that the monomeric form of PrPC
is more likely to gain b-sheets. Our results suggest that if
dimerization plays an important role in the transition from
PrPC to PrPSc, some factors are required to enhance it.
Kaneko et al. (1997) posited the existence of a molecular
chaperone, protein X, and Tompa et al. (2002) proposed
a disulﬁde-reshufﬂing model that is based on contacts
between PrPC and PrPSc dimers and disulﬁde rearrange-
ment(s). Our simulations were performed mainly on the
well-ordered part of HuPrPC (residues 125–228 in the
monomer and 119–226 and 227–334 in the dimer, termed the
C-terminal region). In addition, N-terminal residues 90–124,
truncated in the present model, are required for a-helix-to-b-
sheet transition and for prion disease infectivity (Prusiner,
1982; Pan et al., 1993; Muramoto et al., 1996). Current
simulation models will continue to yield insights into the
structure, function, and dynamics of PrP, and work is
continuing in our laboratory to elucidate the dynamics,
structural change(s), and other factors that involve the
monomeric and dimeric forms of PrP.
CONCLUSION
Ours is the ﬁrst reported exploration of the dynamics of
dimeric PrPC, residues 119–226, using MD simulation to
assess whether the dimer is essential for the conformational
transition of PrPC to PrPSc. Our results showed that
denaturation of helices and elongation of the b-sheet were
common to both the monomer and dimer. However,
additional secondary structure elements formed in the dimer
might result in the greater retention of dimeric than
monomeric tertiary structure. Our results suggest that if
dimerization plays an important role in the transition from
PrPC to PrPSc, some factors are required to enhance it. At
present, we cannot rule out the possibility that dimerization
of HuPrP is a necessary step in the transition from PrPC to
PrPSc. Efforts are under way in our laboratory to perform
simulations of PrP 27–30, residues 90–231, to gain a better
understanding of the underlying process(es) of conforma-
tional change from PrPC to PrPSc.
The authors thank Dr. M. Gromiha, Dr. S. Nakamura, Dr. K. Shimizu, Dr.
M. Suwa, and Dr. T. Hirokawa for helpful discussions.
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